Understand market trends, develop licensing strategies, and identify opportunities in the CGT segment for GI diseases. Dublin, May 30, 2025 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapies in ...

AURORA: A single arm, multicentre, phase II clinical trial of atezolizumab immunotherapy for advanced squamous cell carcinoma of the bladder and urinary tract. Sasanlimab in combination with bacillus ...

Effect of erythrocyte-antibody conjugates on cancers resistant to checkpoint blockade immunotherapy: A phase I trial. The abstract by Luo et al, entitled “Phase 1 clinical trial of EpCAMCAR-T cell ...

More than 90 percent of the serotonin in our body is found in certain cells of the gastrointestinal mucosa and the nervous system. Both the intestines and the stomach are involved in hormonal ...

Apr. 24, 2024 — People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a new study.

This review will discuss the role of mucosal mast cells in the gastrointestinal tract with a specific focus on recent advances in disease mechanisms and clinical management in irritable bowel syndrome ...

This may include: People who are vegan or vegetarian Pregnant people who are vegan or vegetarian Older adults People with pernicious anemia People with GI disorders and/or a history of GI surgery ...

rate of only 25% in patients with stage 3-4 GI involvement. Mesenchymal stromal cells (MSC) have emerged as a promising therapeutic option due to their favorable efficacy and safety profile. However, ...

The final, formatted version of the article will be published soon. Gastric cancer remains one of the most lethal malignancies worldwide. Endoscopic submucosal dissection (ESD), a minimally invasive ...

With clinical manifestations primarily confined to the gastrointestinal tract or attributable to malabsorption, it was logical to assume that the target organ and hence the key to the pathogenesis of ...